2021
DOI: 10.1016/j.jep.2021.113914
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Shengmai San on key enzymes involved in hepatic and intestinal drug metabolism in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
21
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(21 citation statements)
references
References 41 publications
0
21
0
Order By: Relevance
“…SMS selectively suppressed intestinal, but not hepatic, nifedipine oxidation (a CYP3A marker reaction) activity in a dose-and time-dependent manner. Three-week SMS treatment decreased the maximal velocity of intestinal nifedipine oxidation by 50%, while the CYP3A protein level remained unchanged; among the SMS component herbs, the decoction of Ophiopogonis Radix decreased the intestinal nifedipine oxidation activity [195]. Based on an inhibition kinetic investigation of various UGT isoforms, ophiopogonin D was found to noncompetitively inhibit UGT1A6 (K i , 20.6 µmol/L) and competitively inhibit UGT1A8 (40.1 µmol/L); ophiopogonin D' noncompetitively inhibited UGT1A6 (5.3 µmol/L) and UGT1A10 (9.0 µmol/L); and ruscorectal competitively inhibited UGT1A4 (0.02 µmol/L) [106].…”
Section: Shengmai Formulamentioning
confidence: 92%
“…SMS selectively suppressed intestinal, but not hepatic, nifedipine oxidation (a CYP3A marker reaction) activity in a dose-and time-dependent manner. Three-week SMS treatment decreased the maximal velocity of intestinal nifedipine oxidation by 50%, while the CYP3A protein level remained unchanged; among the SMS component herbs, the decoction of Ophiopogonis Radix decreased the intestinal nifedipine oxidation activity [195]. Based on an inhibition kinetic investigation of various UGT isoforms, ophiopogonin D was found to noncompetitively inhibit UGT1A6 (K i , 20.6 µmol/L) and competitively inhibit UGT1A8 (40.1 µmol/L); ophiopogonin D' noncompetitively inhibited UGT1A6 (5.3 µmol/L) and UGT1A10 (9.0 µmol/L); and ruscorectal competitively inhibited UGT1A4 (0.02 µmol/L) [106].…”
Section: Shengmai Formulamentioning
confidence: 92%
“…A 1-h pretreatment of rats with SMS decreased nifedipine clearance, accompanied by decreased hepatic oxidation activity, which was primarily catalyzed by CYP3A [ 133 ]. However, 3-week repeated oral treatments with SMS suppressed rat intestinal, but not hepatic, nifedipine oxidation activity [ 134 ]. Accordingly, nifedipine clearance decreased and AUC t increased.…”
Section: Potential Hdis Between Tcm Formulas and Prescribed Cvd Drugsmentioning
confidence: 99%
“…of S. chinensis extract (equivalent to 15 mg/kg schisandrol B), the oral absolute bioavailability of schisandrol B was approximately 18.73% and 68.12%, respectively [16]. Schisandrin B could modulate cytochrome P450 3A activity (CYP3A) in vivo in rats and also altered the pharmacokinetic profiles of other CYP3A substrates [17]. The tissue distribution studies showed that schisandrin B [18] and schisandrol B were distributed throughout several tested tissues and accumulated mainly in in the liver and kidneys [16,18].…”
Section: Bioavailability Of Schisandra Chinensis Fruit Extract and Its Constituentsmentioning
confidence: 99%
“…Antioxidants 2021, 10, x FOR PEER REVIEW 3 of 11 other CYP3A substrates [17]. The tissue distribution studies showed that schisandrin B [18] and schisandrol B were distributed throughout several tested tissues and accumulated mainly in in the liver and kidneys [16,18].…”
Section: Biological Activity Of Schisandra Chinensis Fruit Extract and Its Constituents: Main Mechanisms Of Actionmentioning
confidence: 99%